Rhoads, D. D., Cherian, S. S., Roman, K., Stempak, L. M., Schmotzer, C. L., & Sadri, N. (2020). Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19. J Clin Microbiol.
Styl ChicagoRhoads, Daniel D., Sree S. Cherian, Katharine Roman, Lisa M. Stempak, Christine L. Schmotzer, a Navid Sadri. "Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 From Nasopharyngeal and Nasal Swabs From Individuals Diagnosed With COVID-19." J Clin Microbiol 2020.
Citace podle MLARhoads, Daniel D., et al. "Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 From Nasopharyngeal and Nasal Swabs From Individuals Diagnosed With COVID-19." J Clin Microbiol 2020.